Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |